Psychological Impact of a Sophrological Accompaniment During the Announcement of Thyroid Cancer
NCT03639662 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 232
Last updated 2018-08-21
Summary
Follicular thyroid cancers are excellent prognoses. However, there is a very clear negative impact of the diagnosis on patients' quality of life, partly because of initial care. The therapeutic sequence is often the following: surgery and complementary administration of radioactive iodine 131. This treatment will destroy all thyroid cells remaining and thus minimize the risk of recurrence and facilitate future controls.
Radioactive iodine uptake is optimized by stimulating thyroid cells that fix iodine better when the level of TSH is high. For this purpose, hypothyroidism is induced by weaning in hormone replacement therapy or injected with recombinant TSH.
Then, a full-body scintigraphy extension is performed followed by a medical consultation. This scintigraphy shows the tissues that fixed the iodine 131, the residual tissues after surgery and / or possible distant metastases.
It is recognized that when a patient learns that he has thyroid cancer, he is subject to increasing anxiety between the time of diagnosis and post-treatment scintigraphy. These patients and their loved ones are often distraught and anticipate their future in a negative way, while long-term survival is excellent. How to get these patients to consider their pathology more objectively and thus reduce their anxiety?
Sophrology is a psychocorporal method aimed at balancing our emotions, thoughts and behaviors. We suppose that if these patients could benefit from a sophrological accompaniment between the announcement of the diagnosis and the scintigraphy, they could apprehend their pathology with more serenity and reality.
No studies providing sophrological support to patients with thyroid cancer have been performed. The anxiety of these patients being largely linked to a feeling of isolation and excessive danger, we think that this care will have an immediate favorable effect on their anxiety, or even in the longer term on their quality of life.
The aim is to offer patients a sophrological support provided by each of the 3 participating centers. These group sessions will allow them to understand the place of their future hospitalization, to share with other patients, to obtain answers to their questions, to be listened to with neutrality and empathy, and to learn management techniques. their anxiety in order to reproduce them at home. They will be followed and will not feel abandoned in the face of their distress.
Conditions
- Follicular Thyroid Cancer
Interventions
- OTHER
-
sophrology sessions
Patients benefit from additional support consisting of at least 3 sessions of sophrology, one per week, from the week following the announcement of the diagnosis and until the week preceding the hospitalization for irathérapie. It will be group sessions, 1h carried out in the participating center by a nurse sophrologist who will use the techniques of sophrology such as relaxation, breath control, mastery of thoughts and visualization. Each session will be recorded in digital format and the recording will be given to the patient at the end of the session so that he can, if he wishes, reproduce it at home. Patients will also be able to share their feelings and ask questions
Sponsors & Collaborators
-
Assistance Publique Hopitaux De Marseille
lead OTHER
Principal Investigators
-
EMILIE GARRIDO PRADALIE · APHM
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-09-30
- Primary Completion
- 2022-03-31
- Completion
- 2022-11-30
Countries
- France
Study Locations
More Related Trials
-
Long-term Survival Outcomes of Total Thyroidectomy and Radioactive Iodine Therapy in Unilateral T3/T4 FTC
NCT06437873 ·Status: COMPLETED
-
Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers
NCT00336102 ·Status: COMPLETED
-
Radioiodine Planar and a SPECT/CT Imaging With Iodine-123 for Evaluation of Follicular Thyroid Nodules Prior to Surgery
NCT05591092 ·Status: COMPLETED
-
Alterations in Quality of Life After Thyroidectomy for Benign Thyroid Disease
NCT03566537 ·Status: COMPLETED
-
Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer
NCT02393690 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of T4 Versus T4/T3 on Psychological Distress After Total Thyroidectomy in Thyroid Cancer Patients
NCT03024151 ·Status: COMPLETED ·Phase: NA
-
Quality of Life Evaluation (SF-36) in Patients With Permanent Hypoparathyroidism After Total Thyroidectomy (Qol-Hypopara)
NCT04053647 ·Status: COMPLETED
-
HRQOL in Thyroid Cancer and Thyroid Tumours
NCT03676348 ·Status: RECRUITING
-
Primary Care Transfer for Thyroid Cancer Patients
NCT03794375 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Medico-Economic Comparison of Four Strategies of Radioiodine Ablation in Thyroid Carcinoma Patients
NCT00435851 ·Status: UNKNOWN ·Phase: PHASE3
-
Testing a Web-based Intervention for Radioactive Iodine Symptom Management to Improve Health-related Quality of Life Among Differentiated Thyroid Cancer Patients
NCT06853925 ·Status: RECRUITING ·Phase: NA
-
Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients?
NCT01837745 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Decision Making and Psychological Outcomes in Low-Risk Papillary Thyroid Cancer
NCT03300284 ·Status: COMPLETED
-
Clinical Efficacy of 125I Seed Implantation in the Treatment of Refractory Differentiated Thyroid Cancer
NCT06362772 ·Status: COMPLETED
-
Assessment of Quality of Life After Adjunct Radioiodine Therapy in Patients With Differentiated Thyroid Cancer
NCT02706743 ·Status: UNKNOWN
-
Decision Aid and Thyroid Nodules Management
NCT05264857 ·Status: RECRUITING ·Phase: NA
-
OnT4-Thyroglobulin Assay Before rhTSH-Aided Radioiodine Ablation
NCT00439127 ·Status: COMPLETED
-
Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC
NCT05668962 ·Status: RECRUITING ·Phase: PHASE2
-
the Microbiota Are Associated With Iodine-131 Therapy and Hypothyroidism
NCT03574051 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Differentiation of Benign From Malignant Thyroid Nodules Using Diffuse Reflectance Spectroscopy
NCT07124065 ·Status: ACTIVE_NOT_RECRUITING
-
Developing and Implementing an Interdisciplinary Team-Based Care Approach (ITCA-ThyCa) for Thyroid Cancer Patients
NCT01994200 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Scientific Protocol for the Study of Thyroid Cancer and Other Thyroid Disease in Belarus Following the Chernobyl Accident
NCT00339716 ·Status: COMPLETED
-
Differentiated Thyroid Cancer Patients Treated With Different Doses of Radioactive Iodine.
NCT06134830 ·Status: NOT_YET_RECRUITING
-
Evaluation of Metformin Effect on the Fertility of Women Treated With 131I for Thyroid Cancer
NCT05468554 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
AIM2: Adequate Selection of Patients for Thyroid Biopsy: Evaluation of a Shared Decision Making Conversation Aid
NCT04463719 ·Status: COMPLETED ·Phase: NA